Buchanan, RW, Heinrichs, DW. The neurological evaluation scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res
1989; 27: 335–50.
Dazzan, P, Murray, RM. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry
2002; 181 (suppl 43): s50–7.
Arango, C, Bartko, JJ, Gold, JM, Buchanan, RW. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am J Psychiatry
1999; 156: 1349–57.
Mohr, F, Hubmann, W, Albus, M, Franz, U, Hecht, S, Scherer, J, Binder, J, Sobizack, N. Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia. Psychiatry Res
2003; 121: 21–30.
Flashman, LA, Flaum, M, Gupta, S, Andreasen, NC. Soft signs and neuropsychological performance in schizophrenia. Am J Psychiatry
1996; 153: 526–32.
King, DJ, Wilson, A, Cooper, SJ, Waddington, JL. The clinical correlates of neurological soft signs in chronic schizophrenia. Br J Psychiatry
1991; 158: 770–5.
Kirkbride, JB, Fearon, P, Morgan, C, Dazzon, P, Morgan, K, Tarrant, J, Lloyd, T, Holloway, J, Hutchinson, G, Leff, JP, Mallet, RM, Harrison, GL, Murray, RM, Jones, PB. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry
2006; 63: 250–8.
World Health Organization. The ICD–10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
Morgan, C, Dazzan, P, Morgan, K, Jones, P, Harrison, G, Leff, J, Murray, K, Fearon, P, AESOP study group. First episode psychosis and ethnicity: initial findings from the AESOP study. World Psychiatry
2006; 5: 40–6.
Bebbington, P, Nayani, T. The Psychosis Screening Questionnaire. Int J Methods Psychiatr Res
1995; 5: 11–9.
World Health Organization. Schedules for Clinical Assessment in Neuropsychiatry
. WHO, 1992.
Wing, JK, Cooper, JE, Sartorius, N. The Measurement and Classification of Psychiatric Symptoms. Cambridge University Press, 1974.
Wing, JK, Sturt, E. The PSE-ID-CATEGO System: Supplementary Manual. Medical Research Council, 1978.
World Health Organization. Personal and Psychiatric History Schedule. WHO, 1996.
Nelson, HE, Willison, JR. National Adult Reading Test (part II) Test Manual. nferNelson, 1991.
Wechsler, D. Wechsler Adult Intelligence Scale – Revised (Manual). The Psychological Corporation, 1981.
Annett, M. A classification of hand preference by association analysis. Br J Psychol
1970; 61: 303–21.
Griffiths, TD, Sigmundsson, T, Takei, N, Rowe, D, Murray, RM. Neurological abnormalities in familial and sporadic schizophrenia. Brain
1998; 121: 191–203.
Sanders, RD, Keshavan, MS, Forman, SD, Pieri, JN, McLaughlin, N, Allen, DN, van Kammen, DP, Goldstein, G. Factor structure of neurologic examination abnormalities in unmedicated schizophrenia. Psychiatry Res
2000; 95: 237–43.
Dazzan, P, Morgan, KD, Orr, KG, Hutchinson, G, Chitnis, X, Suckling, J, Fearon, P, Salvo, J, McGuire, PK, Mallet, RM, Jones, PB, Leff, J, Murray, RM. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain
2004; 127: 143–53.
Simpson, GM, Angus, JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl
1970; 212: 11–9.
Barnes, TRE. A rating scale for drug induced akathisia. Br J Psychiatry
1989; 154: 676.
National Institute of Mental Health. Abnormal Involuntary Movement Scale (AIMS). In ECDEU: Assessment Manual for Psychopharmacology (ed Guy, W): 534–7. Department of Health, Education and Welfare, 1976.
Browne, S, Clarke, M, Gervin, M, Lane, A, Waddington, JL, Larkin, C, O'Callaghan, E. Determinants of neurological dysfunction in first episode schizophrenia. Psychol Med
2000; 30: 1433–41.
Emsley, R, Turner, HJ, Oosthuizen, PP, Carr, J. Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophr Res
2005; 75: 35–44.
Madsen, AL, Vorstrup, S, Rubin, P, Larsen, JK, Hemmingsen, R. Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatr Scand
1999; 100: 119–25.
Cox, SM, Ludwig, AM. Neurological soft signs and psychopathology. I. Findings in schizophrenia. J Nerv Ment Dis
1979; 167: 161–5.
Goswami, U, Sharma, A, Khastigir, U, Ferrier, IN, Young, AH, Gallagher, P, Thompson, JM, Moore, PB. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry
2006; 188: 366–73.
Whitty, P, Clarke, M, McTigue, O, Browne, S, Gervin, M, Kamali, M, Lane, A, Knsella, A, Waddington, J, Larkin, C, O'callaghan, E. Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophr Res
2006; 86: 110–7.
Keshavan, MS, Sanders, RD, Sweeney, JA, Diwadkar, VA, Goldstein, G, Pettegrew, JW, Schooler, NR. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry
2003; 160: 1298–304.
Ho, BC, Mola, C, Andreasen, NC. Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biol Psychiatry
2004; 55: 1146–53.
Mohr, F, Hubmann, W, Cohen, R, Bender, W, Haslacher, C, Honicke, S, Schlenker, R, Wahheim, C, Werther, P. Neurological soft signs in schizophrenia: assessment and correlates. Eur Arch Psychiatry Clin Neurosci
1996; 246: 240–8.
Sanders, RD, Keshavan, MS, Schooler, NR. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am J Psychiatry
1994; 151: 1231–3.
Venkatasubramanian, G, Latha, V, Gangadhar, BN, Janakiramaiah, N, Subbakrishna, DK, Jayakumar, PN, Keshavan, MS. Neurological soft signs in never-treated schizophrenia. Acta Psychiatr Scand
2003; 108: 144–6.
Yazici, AH, Demir, B, Yazici, KM, Gogus, A. Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophr Res
2002; 58: 241–6.
Lawrie, SM, Byrne, M, Miller, P, Hodges, A, Clafferty, RA, Cunningham Owen, DG, Johnson, EC
Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry
2001; 178: 524–30.
Cuesta, MJ, Peralta, V, Zarzuela, A, Calvo, R, Garcia, M, Serrano, F. Neurological soft-signs in psychosis: threshold criteria for discriminating normal controls and for predicting cognitive impairment. Schizophr Res
2002; 58: 263–71.
Dazzan, P, Morgan, KD, Chitnis, X, Suckling, J, Morgan, C, Fearon, P, McGuire, PK, Jones, PB, Leff, J, Murray, RM. The structural brain correlates of neurological soft signs in healthy individuals. Cereb Cortex
2005; 16: 1225–31.